{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COX-B4", "Cathepsin L", "Coleus forskohlii", "Forskolin", "HAV", "HSV-1", "HSV-2", "MD simulation", "virtual screening"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38338448", "DateCompleted": {"Year": "2024", "Month": "02", "Day": "14"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "14"}, "Article": {"Language": ["eng"], "ELocationID": ["704", "10.3390/molecules29030704"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "03"}], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "29", "Issue": "3", "PubDate": {"Year": "2024", "Month": "Feb", "Day": "03"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Unveiling the Antiviral Efficacy of Forskolin: A Multifaceted In Vitro and In Silico Approach.", "Abstract": {"AbstractText": ["<i>Coleus forskohlii</i> (Willd.) Briq. is a medicinal herb of the Lamiaceae family. It is native to India and widely present in the tropical and sub-tropical regions of Egypt, China, Ethiopia, and Pakistan. The roots of <i>C. forskohlii</i> are edible, rich with pharmaceutically bioactive compounds, and traditionally reported to treat a variety of diseases, including inflammation, respiratory disorders, obesity, and viral ailments. Notably, the emergence of viral diseases is expected to quickly spread; consequently, these data impose a need for various approaches to develop broad active therapeutics for utilization in the management of future viral infectious outbreaks. In this study, the naturally occurring labdane diterpenoid derivative, Forskolin, was obtained from <i>Coleus forskohlii</i>. Additionally, we evaluated the antiviral potential of Forskolin towards three viruses, namely the herpes simplex viruses 1 and 2 (HSV-1 and HSV-2), hepatitis A virus (HAV), and coxsackievirus B4 (COX-B4). We observed that Forskolin displayed antiviral activity against HAV, COX-B4, HSV-1, and HSV-2 with IC<sub>50</sub> values of 62.9, 73.1, 99.0, and 106.0 \u03bcg/mL, respectively. Furthermore, we explored the Forskolin's potential antiviral target using PharmMapper, a pharmacophore-based virtual screening platform. Forskolin's modeled structure was analyzed to identify potential protein targets linked to its antiviral activity, with results ranked based on Fit scores. Cathepsin L (PDB ID: 3BC3) emerged as a top-scoring hit, prompting further exploration through molecular docking and MD simulations. Our analysis revealed that Forskolin's binding mode within Cathepsin L's active site, characterized by stable hydrogen bonding and hydrophobic interactions, mirrors that of a co-crystallized inhibitor. These findings, supported by consistent RMSD profiles and similar binding free energies, suggest Forskolin's potential in inhibiting Cathepsin L, highlighting its promise as an antiviral agent."]}, "AuthorList": [{"Identifier": ["0000-0003-2552-4567"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt."}], "LastName": "Amen", "ForeName": "Yhiya", "Initials": "Y"}, {"Identifier": ["0000-0002-5539-7274"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Selim", "ForeName": "Mohamed A", "Initials": "MA"}, {"Identifier": ["0000-0001-8080-1104"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Suef", "ForeName": "Reda A", "Initials": "RA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Collage of Pharmacy, Almaaqal University, Basrah 61014, Iraq."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Nahda University, Beni-Suef 62513, Egypt."}], "LastName": "Sayed", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0002-2827-7621"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Othman", "ForeName": "Ahmed", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "1F7A44V6OU", "NameOfSubstance": "Colforsin"}, {"RegistryNumber": "EC 3.4.22.15", "NameOfSubstance": "Cathepsin L"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Colforsin"}, {"QualifierName": [], "DescriptorName": "Cathepsin L"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Herpesvirus 1, Human"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Antiviral Agents"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Calixto J.B. The role of natural products in modern drug discovery. An. Acad. Bras. Ci\u00eancias. 2019;91((Suppl. S3)):e20190105. doi: 10.1590/0001-3765201920190105.", "ArticleIdList": ["10.1590/0001-3765201920190105", "31166478"]}, {"Citation": "Lahlou M. The Success of Natural Products in Drug Discovery. Pharmacol. Pharm. 2013;4:17\u201331. doi: 10.4236/pp.2013.43A003.", "ArticleIdList": ["10.4236/pp.2013.43A003"]}, {"Citation": "Clark A.M. Natural products as a resource for new drugs. Pharm. Res. 1996;13:1133\u20131141. doi: 10.1023/A:1016091631721.", "ArticleIdList": ["10.1023/A:1016091631721", "8865302"]}, {"Citation": "Dzobo K. The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery. Compr. Pharmacol. 2022:408\u2013422. doi: 10.1016/b978-0-12-820472-6.00041-4.", "ArticleIdList": ["10.1016/b978-0-12-820472-6.00041-4"]}, {"Citation": "Christenhusz M.J.M., Byng J.W. The number of known plants species in the world and its annual increase. Phytotaxa. 2016;261:201. doi: 10.11646/phytotaxa.261.3.1.", "ArticleIdList": ["10.11646/phytotaxa.261.3.1"]}, {"Citation": "MNPS Medicinal Plant Names Services (MNPS)  [(accessed on 14 August 2021)].  Available online:  https://www.kew.org/science/our-science/science-services/medicinal-plant-names-services."}, {"Citation": "Tajkarimi M.M., Ibrahim S.A., Cliver D.O. Antimicrobial herb and spice compounds in food. Food Control. 2010;21:1199\u20131218. doi: 10.1016/j.foodcont.2010.02.003.", "ArticleIdList": ["10.1016/j.foodcont.2010.02.003"]}, {"Citation": "Ali S.I., Sheikh W.M., Rather M.A., Venkatesalu V., Muzamil Bashir S., Nabi S.U. Medicinal plants: Treasure for antiviral drug discovery. Phytother. Res. 2021;35:3447\u20133483. doi: 10.1002/ptr.7039.", "ArticleIdList": ["10.1002/ptr.7039", "PMC8013762", "33590931"]}, {"Citation": "Biron K.K. Antiviral drugs for cytomegalovirus diseases. Antivir. Res. 2006;71:154\u2013163. doi: 10.1016/j.antiviral.2006.05.002.", "ArticleIdList": ["10.1016/j.antiviral.2006.05.002", "16765457"]}, {"Citation": "Sharma R., Bhattu M., Tripathi A., Verma M., Acevedo R., Kumar P., Rajput V.D., Singh J. Potential medicinal plants to combat viral infections: A way forward to environmental biotechnology. Environ. Res. 2023;227:115725. doi: 10.1016/j.envres.2023.115725.", "ArticleIdList": ["10.1016/j.envres.2023.115725", "37001848"]}, {"Citation": "Achilonu C.C., Udensi O.U. Systematic Review of Antimicrobial Activities of Medicinal Plants against Bacterial and Fungal Microbes: A Research Trend in Africa from 1980 to 2019. Research Square; Durham, NC, USA: 2022.", "ArticleIdList": ["10.21203/rs.3.rs-1529001/v1"]}, {"Citation": "Pullaiah T. Forskolin. Springer; Berlin/Heidelberg, Germany: 2022. Coleus forskohlii\u2014A Multipurpose Medicinal Plant; pp. 1\u20133.", "ArticleIdList": ["10.1007/978-981-19-6521-0_1"]}, {"Citation": "Sivakumar P., Bavithra V., Ashokkumar K., Deepadharsini R., Selvaraj K.V., Gopal M. Comprehensive review on phytochemistry and in vitro biotechnology of Coleus forskohlii. J. Pharmacogn. Phytochem. 2021;10:448\u2013453. doi: 10.22271/phyto.2021.v10.i1g.13346.", "ArticleIdList": ["10.22271/phyto.2021.v10.i1g.13346"]}, {"Citation": "Ju H., Zhang C., Lu W. Progress in heterologous biosynthesis of forskolin. J. Ind. Microbiol. Biotechnol. 2021;48:kuab009. doi: 10.1093/jimb/kuab009.", "ArticleIdList": ["10.1093/jimb/kuab009", "PMC9113163", "33928347"]}, {"Citation": "Mukherjee P.K. Bioactive Phytocomponents and Their Analysis. Qual. Control Eval. Herbal Drugs. 2019:237\u2013328. doi: 10.1016/b978-0-12-813374-3.00007-7.", "ArticleIdList": ["10.1016/b978-0-12-813374-3.00007-7"]}, {"Citation": "Kumari A., Kumar P., Kumar M., Kumar J. In Silico Analysis of Forskolin as a Potential Inhibitor of SARS-CoV-2. J. Pure Appl. Microbiol. 2021;15:709\u2013715. doi: 10.22207/JPAM.15.2.22.", "ArticleIdList": ["10.22207/JPAM.15.2.22"]}, {"Citation": "Patel M.B. Forskolin: A successful therapeutic phytomolecule. East Central Afr. J. Pharm. Sci. 2010;13:25\u201332."}, {"Citation": "James C., Harfouche M., Welton N.J., Turner K.M., Abu-Raddad L.J., Gottlieb S.L., Looker K.J. Herpes simplex virus: Global infection prevalence and incidence estimates, 2016. Bull. World Health Organ. 2020;98:315\u2013329. doi: 10.2471/BLT.19.237149.", "ArticleIdList": ["10.2471/BLT.19.237149", "PMC7265941", "32514197"]}, {"Citation": "Zhang S.-Y. Herpes simplex virus encephalitis of childhood: Inborn errors of central nervous system cell-intrinsic immunity. Hum. Genet. 2020;139:911\u2013918. doi: 10.1007/s00439-020-02127-5.", "ArticleIdList": ["10.1007/s00439-020-02127-5", "PMC7739442", "32040615"]}, {"Citation": "Hepatitis A Outbreaks in the United States. Retrieved August 23, 2022, from CDC.  [(accessed on 1 January 2024)]; Available online:  https://www.cdc.gov/hepatitis/outbreaks/hepatitisaoutbreaks.htm."}, {"Citation": "Win N.N., Kanda T., Ogawa M., Nakamoto S., Haga Y., Sasaki R., Nakamura M., Wu S., Matsumoto N., Matsuoka S., et al. Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus. Int. J. Med. Sci. 2019;16:1366\u20131370. doi: 10.7150/ijms.32795.", "ArticleIdList": ["10.7150/ijms.32795", "PMC6818197", "31692913"]}, {"Citation": "No\u00ebl L., Tubiana R., Simon A., Valantin M.-A., Palich R., Blanc C., Katlama C., Marcelin A.-G., Calvez V., Todesco E. Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccine. M\u00e9d. Mal. Infect. 2021;51:94\u201396. doi: 10.1016/j.medmal.2020.09.016.", "ArticleIdList": ["10.1016/j.medmal.2020.09.016", "33022294"]}, {"Citation": "Ndumbi P., Freidl G.S., Williams C.J., M\u00e5rdh O., Varela C., Avell\u00f3n A., Friesema I., Vennema H., Beebeejaun K., Ngui S.L., et al. Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area. Eurosurveillance. 2018;23:1700641. doi: 10.2807/1560-7917.ES.2018.23.33.1700641.", "ArticleIdList": ["10.2807/1560-7917.ES.2018.23.33.1700641", "PMC6205254", "30131095"]}, {"Citation": "Jmii H., Halouani A., Maatouk M., Chekir-Ghedira L., Aouni M., Fisson S., Ja\u00efdane H. Coxsackievirus B4 infection and interneuronal spread in primary cultured neurons. Microb. Pathog. 2020;145:104235. doi: 10.1016/j.micpath.2020.104235.", "ArticleIdList": ["10.1016/j.micpath.2020.104235", "32360191"]}, {"Citation": "Liu X., Ouyang S., Yu B., Liu Y., Huang K., Gong J., Zheng S., Li Z., Li H., Jiang H. PharmMapper server: A web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res. 2010;38((Suppl. S2)):W609\u2013W614. doi: 10.1093/nar/gkq300.", "ArticleIdList": ["10.1093/nar/gkq300", "PMC2896160", "20430828"]}, {"Citation": "Chowdhury S.F., Joseph L., Kumar S., Shenoy R.T., Bhat S., Ziomek E., M\u00e9nard R., Sivaraman J., Purisima E.O. Exploring inhibitor binding at the S\u2032 subsites of cathepsin L. J. Med. Chem. 2008;51:1361\u20131368. doi: 10.1021/jm701190v.", "ArticleIdList": ["10.1021/jm701190v", "18278855"]}, {"Citation": "Mondal S., Chen Y., Lockbaum G.J., Sen S., Chaudhuri S., Reyes A.C., Lee J.M., Kaur A.N., Sultana N., Cameron M.D., et al. Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2. J. Am. Chem. Soc. 2022;144:21035\u201321045. doi: 10.1021/jacs.2c04626.", "ArticleIdList": ["10.1021/jacs.2c04626", "PMC9662648", "36356199"]}, {"Citation": "Jeong J.H., Choi J.H., Kim B.K., Min S.C., Chokkakula S., Oh S., Park J.H., Shim S.M., Kim E.G., Choi Y.K., et al. Evaluating Z-FA-FMK, a host cathepsin L protease inhibitor, as a potent and broad-spectrum antiviral therapy against SARS-CoV-2 and related coronaviruses. Antivir. Res. 2023;216:105669. doi: 10.1016/j.antiviral.2023.105669.", "ArticleIdList": ["10.1016/j.antiviral.2023.105669", "37437781"]}, {"Citation": "Hopkins J., Yadavalli T., Agelidis A.M., Shukla D. Host enzymes heparanase and cathepsin L promote herpes simplex virus 2 release from cells. J. Virol. 2018;92:10\u20131128. doi: 10.1128/JVI.01179-18.", "ArticleIdList": ["10.1128/JVI.01179-18", "PMC6232460", "30232188"]}, {"Citation": "Scarcella M., d\u2019Angelo D., Ciampa M., Tafuri S., Avallone L., Pavone L.M., De Pasquale V. The key role of lysosomal protease cathepsins in viral infections. Int. J. Mol. Sci. 2022;23:9089. doi: 10.3390/ijms23169089.", "ArticleIdList": ["10.3390/ijms23169089", "PMC9409221", "36012353"]}, {"Citation": "Manchanda M., Das P., Gahlot G.P.S., Singh R., Roeb E., Roderfeld M., Datta Gupta S., Saraya A., Pandey R.M., Chauhan S.S. Cathepsin L and B as potential markers for liver fibrosis: Insights from patients and experimental models. Clin. Transl. Gastroenterol. 2017;8:e99. doi: 10.1038/ctg.2017.25.", "ArticleIdList": ["10.1038/ctg.2017.25", "PMC5518948", "28617446"]}, {"Citation": "Kl\u00f6hn M., Burkard T., Janzen J., Schrader J.A., G\u00f6mer A., Brown R.J., Dao Thi V.L., Kinast V., Br\u00fcggemann Y., Todt D., et al. Targeting cellular cathepsins inhibits hepatitis E virus infection. bioRxiv. 2023 doi: 10.1101/2023.11.03.565430.", "ArticleIdList": ["10.1101/2023.11.03.565430"]}, {"Citation": "Wang Y., Jia L., Shen J., Wang Y., Fu Z., Su S.A., Cai Z., Wang J.A., Xiang M. Cathepsin B aggravates coxsackievirus B3-induced myocarditis through activating the inflammasome and promoting pyroptosis. PLoS Pathog. 2018;14:e1006872. doi: 10.1371/journal.ppat.1006872.", "ArticleIdList": ["10.1371/journal.ppat.1006872", "PMC5809100", "29360865"]}, {"Citation": "Mohamud Y., Tang H., Xue Y.C., Liu H., Ng C.S., Bahreyni A., Luo H. Coxsackievirus B3 targets TFEB to disrupt lysosomal function. Autophagy. 2021;17:3924\u20133938. doi: 10.1080/15548627.2021.1896925.", "ArticleIdList": ["10.1080/15548627.2021.1896925", "PMC8726691", "33691586"]}, {"Citation": "Liu T., Luo S., Libby P., Shi G.P. Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients. Pharmacol. Ther. 2018;213:107587. doi: 10.1016/j.pharmthera.2020.107587.", "ArticleIdList": ["10.1016/j.pharmthera.2020.107587", "PMC7255230", "32470470"]}, {"Citation": "Zhu J.D., Meng W., Wang X.J., Wang H.C.R. Broad-spectrum antiviral agents. Front. Microbiol. 2015;6:517. doi: 10.3389/fmicb.2015.00517.", "ArticleIdList": ["10.3389/fmicb.2015.00517", "PMC4440912", "26052325"]}, {"Citation": "Elshabrawy H.A., Fan J., Haddad C.S., Ratia K., Broder C.C., Caffrey M., Prabhakar B.S. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay. J. Virol. 2014;88:4353\u20134365. doi: 10.1128/JVI.03050-13.", "ArticleIdList": ["10.1128/JVI.03050-13", "PMC3993759", "24501399"]}, {"Citation": "Abdullah N., Abdulghani R., Ismail S.M., Abidin M.H.Z. Immune-stimulatory potential of hot water extracts of selected edible mushrooms. Food Agric. Immunol. 2017;28:374\u2013387. doi: 10.1080/09540105.2017.1293011.", "ArticleIdList": ["10.1080/09540105.2017.1293011"]}, {"Citation": "Wang X., Shen Y., Wang S., Li S., Zhang W., Liu X., Lai L., Pei J., Li H. PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45:W356\u2013W360. doi: 10.1093/nar/gkx374.", "ArticleIdList": ["10.1093/nar/gkx374", "PMC5793840", "28472422"]}, {"Citation": "Kerwin S.M. ChemBioOffice ultra 2010 suite. J. Am. Chem. Soc. 2010;132:2466\u20132467. doi: 10.1021/ja1005306.", "ArticleIdList": ["10.1021/ja1005306", "20121088"]}, {"Citation": "Huey R., Morris G.M., Forli S. Using AutoDock 4 and AutoDock vina with AutoDockTools: A tutorial. Scripps Res. Inst. Mol. Graph. Lab. 2012;10550:1000."}, {"Citation": "Salmaso V., Moro S. Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview. Front. Pharmacol. 2018;9:923. doi: 10.3389/fphar.2018.00923.", "ArticleIdList": ["10.3389/fphar.2018.00923", "PMC6113859", "30186166"]}, {"Citation": "Phillips J.C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel R.D., Kal\u00e9 L., Schulten K. Scalable molecular dynamics with NAMD. J. Comput. Chem. 2005;26:1781\u20131802. doi: 10.1002/jcc.20289.", "ArticleIdList": ["10.1002/jcc.20289", "PMC2486339", "16222654"]}, {"Citation": "Ribeiro J.V., Bernardi R.C., Rudack T., Schulten K., Tajkhorshid E. QwikMD-Gateway for Easy Simulation with VMD and NAMD. Biophys. J. 2018;114:673a\u2013674a. doi: 10.1016/j.bpj.2017.11.3632.", "ArticleIdList": ["10.1016/j.bpj.2017.11.3632", "PMC5985026", "29414703"]}, {"Citation": "Humphrey W., Dalke A., Schulten K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996;14:33\u201338. doi: 10.1016/0263-7855(96)00018-5.", "ArticleIdList": ["10.1016/0263-7855(96)00018-5", "8744570"]}, {"Citation": "Miller B.R., III, McGee T.D., Jr., Swails J.M., Homeyer N., Gohlke H., Roitberg A.E. MMPBSA. py: An efficient program for end-state free energy calculations. J. Chem. Theory Comput. 2012;8:3314\u20133321. doi: 10.1021/ct300418h.", "ArticleIdList": ["10.1021/ct300418h", "26605738"]}]}], "History": [{"Year": "2024", "Month": "1", "Day": "2"}, {"Year": "2024", "Month": "1", "Day": "27"}, {"Year": "2024", "Month": "2", "Day": "1"}, {"Year": "2024", "Month": "2", "Day": "10", "Hour": "14", "Minute": "45"}, {"Year": "2024", "Month": "2", "Day": "10", "Hour": "10", "Minute": "52"}, {"Year": "2024", "Month": "2", "Day": "10", "Hour": "1", "Minute": "9"}, {"Year": "2024", "Month": "2", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["38338448", "PMC10856047", "10.3390/molecules29030704", "molecules29030704"]}}]}